Edward R Smith Jr, MD | |
900 23rd St Nw, Washington, DC 20037-2342 | |
(202) 715-4911 | |
(202) 741-3396 |
Full Name | Edward R Smith Jr |
---|---|
Gender | Male |
Speciality | Emergency Medicine - Emergency Medical Services |
Location | 900 23rd St Nw, Washington, District Of Columbia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225100696 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | MD 34019 (District Of Columbia) | Primary |
207PE0004X | Emergency Medicine - Emergency Medical Services | MD34019 (District Of Columbia) | Primary |
Entity Name | Arlington County Government Department Of Managment & Finance |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043280415 PECOS PAC ID: 7214928803 Enrollment ID: O20040521000703 |
News Archive
The International Osteoporosis Foundation, along with the European Society for Calcified Tissue, launched new guidance on glucocorticoid use at the European Congress on Osteoporosis and Osteoarthritis (which took place in Bordeaux from March 21 - 24, 2012). Given the special relevance to postmenopausal women, the International Menopause Society (IMS) is supporting the publication of the guidance.
University of Liverpool researchers, working with F2G Limited (Eccles, Manchester), have developed a new antifungal drug to help in the treatment of life threatening invasive fungal infections such as invasive aspergillosis.
Researchers at Mount Sinai School of Medicine have found that a compound called NIC5-15, might be a safe and effective treatment to stabilize cognitive performance in patients with mild to moderate Alzheimer's disease.
Poor social functioning in childhood predicts an increased risk for schizophrenia later in life, suggest researchers.
› Verified 3 days ago
Entity Name | Emergency Medicine Associates Pa Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1134117393 PECOS PAC ID: 8022914522 Enrollment ID: O20070919000389 |
News Archive
The International Osteoporosis Foundation, along with the European Society for Calcified Tissue, launched new guidance on glucocorticoid use at the European Congress on Osteoporosis and Osteoarthritis (which took place in Bordeaux from March 21 - 24, 2012). Given the special relevance to postmenopausal women, the International Menopause Society (IMS) is supporting the publication of the guidance.
University of Liverpool researchers, working with F2G Limited (Eccles, Manchester), have developed a new antifungal drug to help in the treatment of life threatening invasive fungal infections such as invasive aspergillosis.
Researchers at Mount Sinai School of Medicine have found that a compound called NIC5-15, might be a safe and effective treatment to stabilize cognitive performance in patients with mild to moderate Alzheimer's disease.
Poor social functioning in childhood predicts an increased risk for schizophrenia later in life, suggest researchers.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Edward R Smith Jr, MD 2150 Pennsylvania Ave Nw, Washington, DC 20037-3201 Ph: (202) 715-4911 | Edward R Smith Jr, MD 900 23rd St Nw, Washington, DC 20037-2342 Ph: (202) 715-4911 |
News Archive
The International Osteoporosis Foundation, along with the European Society for Calcified Tissue, launched new guidance on glucocorticoid use at the European Congress on Osteoporosis and Osteoarthritis (which took place in Bordeaux from March 21 - 24, 2012). Given the special relevance to postmenopausal women, the International Menopause Society (IMS) is supporting the publication of the guidance.
University of Liverpool researchers, working with F2G Limited (Eccles, Manchester), have developed a new antifungal drug to help in the treatment of life threatening invasive fungal infections such as invasive aspergillosis.
Researchers at Mount Sinai School of Medicine have found that a compound called NIC5-15, might be a safe and effective treatment to stabilize cognitive performance in patients with mild to moderate Alzheimer's disease.
Poor social functioning in childhood predicts an increased risk for schizophrenia later in life, suggest researchers.
› Verified 3 days ago
Emily Jean Siegel, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-8080 | |
Todd Templeman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 110 Irving St Nw, Suite Na-1177, Washington, DC 20010 Phone: 202-877-7632 Fax: 202-877-2468 | |
James A. D'orta, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1700 Pennsylvania Ave Nw, Suite 550, Washington, DC 20006 Phone: 202-955-0000 | |
Guenevere Vanessa Burke, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 50 Irving St Nw, Washington, DC 20422 Phone: 202-741-3581 | |
Jennifer Yu, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, C/o Surgical Critical Care Services, Washington, DC 20010 Phone: 202-877-7000 | |
Diane A Sauter, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3800 Reservoir Rd Nw, Washington, DC 20007 Phone: 202-444-2119 | |
Namman N Halabi, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1150 Varnum St Ne, Washington, DC 20017 Phone: 202-269-7000 |